Literature DB >> 26411324

What we know, what we do not know, and where are we heading? Efficacy and acceptability of psychological interventions for depression.

N Solomonov1, J P Barber1.   

Abstract

In the past several decades, increasing evidence supports the efficacy of psychotherapies for depression. The vast majority of findings from meta-analyses, randomized clinical trials (RCTs) and naturalistic studies have demonstrated that well-established psychotherapies (behavioural activation, problem-solving therapy, psychodynamic therapy, cognitive-behavioural therapy, interpersonal therapy and emotion-focused therapy) are superior to no-treatment and control conditions, and are in most cases equally effective in treating depression. However, despite this abundant support for psychotherapies, studies have also consistently shown high drop-out rates, high percentages of non-respondent patients who experience treatment failures, and mixed findings regarding the enduring effects of psychotherapy. Thus, there is a need to develop more personalised treatment models tailored to patients' needs. A new integrative sequential stepwise approach to the treatment of depression is suggested.

Entities:  

Keywords:  Behaviour therapy; cognitive therapy; depression; evidence-based psychiatry; psychoanalysis and psychodynamic therapies

Mesh:

Year:  2015        PMID: 26411324      PMCID: PMC7137604          DOI: 10.1017/S2045796015000815

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  65 in total

Review 1.  The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis update.

Authors:  Ellen Driessen; Lisa M Hegelmaier; Allan A Abbass; Jacques P Barber; Jack J M Dekker; Henricus L Van; Elise P Jansma; Pim Cuijpers
Journal:  Clin Psychol Rev       Date:  2015-08-01

2.  Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up--a longitudinal meta-analysis.

Authors:  Christoph Flückiger; A C Del Re; Thomas Munder; Sara Heer; Bruce E Wampold
Journal:  Clin Psychol Rev       Date:  2014-05-19

3.  Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

Authors:  Jacques P Barber; Marna S Barrett; Robert Gallop; Moira A Rynn; Karl Rickels
Journal:  J Clin Psychiatry       Date:  2011-11-29       Impact factor: 4.384

4.  Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS).

Authors:  Peter Fonagy; Felicitas Rost; Jo-Anne Carlyle; Susan McPherson; Rachel Thomas; R M Pasco Fearon; David Goldberg; David Taylor
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

5.  The effectiveness of long-term psychoanalytic psychotherapy--a meta-analysis of randomized controlled trials.

Authors:  Yolba Smit; Marcus J H Huibers; John P A Ioannidis; Richard van Dyck; Willem van Tilburg; Arnoud Arntz
Journal:  Clin Psychol Rev       Date:  2011-12-04

Review 6.  Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety.

Authors:  Steven D Hollon; Michael O Stewart; Daniel Strunk
Journal:  Annu Rev Psychol       Date:  2006       Impact factor: 24.137

7.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.

Authors:  Stefan G Hofmann; Anu Asnaani; Imke J J Vonk; Alice T Sawyer; Angela Fang
Journal:  Cognit Ther Res       Date:  2012-07-31

9.  Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.

Authors:  S M Sotsky; D R Glass; M T Shea; P A Pilkonis; J F Collins; I Elkin; J T Watkins; S D Imber; W R Leber; J Moyer
Journal:  Am J Psychiatry       Date:  1991-08       Impact factor: 18.112

10.  Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis.

Authors:  Pim Cuijpers; Steven D Hollon; Annemieke van Straten; Claudi Bockting; Matthias Berking; Gerhard Andersson
Journal:  BMJ Open       Date:  2013-04-26       Impact factor: 2.692

View more
  5 in total

1.  The future of psychotherapy research: stop the waste and focus on issues that matter.

Authors:  P Cuijpers
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-09       Impact factor: 6.892

2.  An experimental test of the fetal programming hypothesis: Can we reduce child ontogenetic vulnerability to psychopathology by decreasing maternal depression?

Authors:  Elysia Poggi Davis; Benjamin L Hankin; Danielle A Swales; M Camille Hoffman
Journal:  Dev Psychopathol       Date:  2018-08

3.  Toward a personalized approach to psychotherapy outcome and the study of therapeutic change.

Authors:  Jacques P Barber; Nili Solomonov
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

4.  Engagement in Socially and Interpersonally Rewarding Activities as a Predictor of Outcome in "Engage" Behavioral Activation Therapy for Late-Life Depression.

Authors:  Nili Solomonov; Jennifer N Bress; Jo Anne Sirey; Faith M Gunning; Christoph Flückiger; Patrick J Raue; Patricia A Areán; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2019-01-10       Impact factor: 4.105

5.  Unpacking the heterogeneity in treatment effects as a path to personalized psychotherapies: Are we there yet?

Authors:  Nili Solomonov; Jacques P Barber
Journal:  Clin Psychol (New York)       Date:  2022-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.